News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ConjuGon, Inc. Raises $3.3 Million


12/13/2006 1:16:20 PM

MADISON, WI -- (MARKET WIRE) -- December 13, 2006 -- ConjuGon, Inc., a privately held biopharmaceutical company focused on developing novel therapies for the treatment of antibiotic resistant bacterial infections, today announced it has raised a $3.3 million investment round. Rosetta Partners, a biotechnology investment group, led the financing with additional investment by the Wisconsin Investment Partners, an organized angel group.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES